Safety and efficacy of botulinum toxin t
โ
Charles H. Adler; Stephen F. Bansberg; Kari Krein-Jones; Joseph G. Hentz
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 68 KB
## Abstract This singleโsite, openโlabel, doseโfinding study evaluated the safety and efficacy of botulinum toxin type B (BoNTโB; Myobloc) for the treatment of adductor spasmodic dysphonia (AdSD) in 13 patients. Three patients received a total of 50 U (25 U per vocal fold); the same three subsequen